At the Milken Global Conference 2025, Dipal Doshi, CEO of Entrada Therapeutics, shared insights on patient-focused drug development and advancing therapies for rare diseases. With extensive experience in biotechnology, investment banking, and life sciences leadership, Dipal emphasizes partnerships with patient advocacy groups to ensure therapies are informed by real-world patient perspectives. He also serves on multiple biotech boards and is a Fellow of the Aspen Institute.

Ian Khan is a globally recognised emerging tech leadership expert. A practising Futurist, Creator of the Future Readiness Leaders Circle, Multiple times author including "Metaverse for Dummies", Filmmaker and Storyteller on PrimeVideo and Emirates Airlines, one of the worlds largest airlines with 10 Million passengers per year. Ian's ground breaking work has been featured on CNN, the BBC, Fox, Bloomberg, Wharton Daily, ArabNews, RT, CoinBase, Korea Times, Spanish Daily Expansión, Ian hosts the worlds largest Future Readiness leadership networks, bringing together high performance entrepreneurs and leaders on a common mission to build future ready and undisputable businesses. Khan's new book is titled "Undisruptable" and is scheduled to release in early 2024.

Visit Ian at www.IanKhan.com